← The Wire
CUENasdaq
Cue Biopharma, Inc.
Pharmaceutical Preparations · DE · CIK 1645460
Developing injectable therapeutics to selectively engage and modulate disease-specific T cells for autoimmune and inflammatory diseases
red 8-K · 90d
$103M
Market cap
$30.43
Last close
+19.9%
1D
-1.0%
5D
164K
Volume
Price · last 39 sessions+1.9%
May 4L $20.03 · H $35.73Jun 29
176
Total filings
Jun 3, 2026
Last filing
12/31
Fiscal year end
8-KExecutive Change · Shareholder VoteJun 3, 20268-KExecutive Change · Company UpdateJun 2, 2026DEF 14ADEF 14AMay 21, 20268-KCompany UpdateMay 14, 202610-Q10-QMay 14, 20268-KExecutive Change · Material AgreementMay 1, 20268-KSecurity-Holder Rights · Bylaw AmendmentApr 22, 20268-KShareholder VoteApr 13, 20268-KCompany UpdateApr 7, 2026DEFA14ADEFA14AMar 27, 20268-KExecutive ChangeMar 27, 2026DEF 14ADEF 14AMar 16, 20268-KResults of OperationsMar 16, 202610-K10-KMar 16, 20268-KCompany UpdateFeb 18, 20268-KExecutive ChangeFeb 12, 20268-KMaterial Agreement · Company UpdateDec 19, 2025424B5424B5Dec 19, 2025424B5424B5Dec 18, 20258-KReg FD DisclosureNov 24, 20258-KExecutive ChangeNov 20, 202510-Q10-QNov 12, 20258-KResults of OperationsNov 12, 20258-KMaterial Agreement · Reg FD DisclosureNov 6, 20258-KExecutive ChangeSep 29, 202510-Q10-QAug 12, 20258-KResults of OperationsAug 12, 20258-KMaterial AgreementJul 1, 20258-KExecutive Change · Bylaw AmendmentJun 10, 2025DEFA14ADEFA14AMay 27, 202510-Q10-QMay 12, 20258-KResults of OperationsMay 12, 2025DEF 14ADEF 14AApr 25, 2025DEFA14ADEFA14AApr 25, 20258-KMaterial Agreement · Results of OperationsApr 15, 2025424B5424B5Apr 15, 2025424B5424B5Apr 14, 20258-KMaterial AgreementApr 14, 20258-KResults of OperationsMar 31, 202510-K10-KMar 31, 20258-KExecutive ChangeMar 12, 202510-Q10-QNov 14, 20248-KResults of OperationsNov 14, 20248-KBylaw Amendment · Shareholder VoteOct 8, 20248-KMaterial AgreementOct 4, 20248-KMaterial Agreement · Company UpdateSep 27, 2024424B5424B5Sep 27, 2024424B5424B5Sep 26, 2024DEF 14ADEF 14ASep 10, 20248-KExecutive ChangeSep 3, 20248-KDelisting NoticeAug 16, 202410-Q10-QAug 14, 20248-KExecutive Change · Company UpdateJul 25, 20248-KExecutive Change · Shareholder VoteJun 7, 2024DEFA14ADEFA14AMay 24, 20248-KResults of OperationsMay 9, 202410-Q10-QMay 9, 2024DEF 14ADEF 14AApr 26, 2024DEFA14ADEFA14AApr 26, 202410-K10-KMar 28, 2024SC 13GCUEBIOPHARMA13GMar 11, 2024SC 13GSC 13GFeb 7, 2024SC 13GSC 13GJan 31, 202410-Q10-QNov 3, 20238-KExecutive ChangeSep 14, 202310-Q10-QAug 8, 20238-KShareholder VoteJun 9, 202310-Q10-QMay 9, 2023DEFA14ADEFA14AApr 28, 2023DEF 14ADEF 14AApr 28, 20238-KExecutive ChangeApr 25, 20238-KExecutive ChangeApr 12, 202310-K10-KMar 21, 20238-KExecutive ChangeMar 10, 2023SC 13GCUE BIOPHARMA, INC.Feb 14, 2023SC 13GSC 13GNov 18, 20228-KMaterial Agreement · Equity IssuanceNov 15, 202210-Q10-QNov 14, 202210-Q10-QAug 4, 2022SC 13GSC 13GJul 8, 2022
Insider Activity
In the 90 days to Dec 30, 2025: 1 insider bought $100K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 30, 2025 | Sarraf PashaDirector | Buy | 86,947 | $0.32 | $28K |
| Dec 30, 2025 | Sarraf PashaDirector | Buy | 78,116 | $0.31 | $24K |
| Dec 30, 2025 | Sarraf PashaDirector | Buy | 77,417 | $0.30 | $23K |
| Dec 30, 2025 | Sarraf PashaDirector | Buy | 77,148 | $0.30 | $23K |
| Dec 30, 2025 | Sarraf PashaDirector | Buy | 4,229 | $0.31 | $1K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance